Regulator
The US FDA granted Virtuoso Surgical's robotic system a new-device authorization to remove bladder tumors through the urethra, the body's urine tube.
A regulator's decision · Sets Virtuoso Surgical Robotic System's stage
What the source says
“The Food and Drug Administration granted de novo authorization to Virtuoso Surgical’s robotic system for endoscopic surgery to remove bladder tumors”
What it means
The authorization moves Virtuoso Surgical to stage 5 on our ladder, the top stage, but the record is thin on what comes next. It shows no customer, pilot or sale, so stage 5 here reflects regulator clearance rather than proven use. The step follows the breakthrough device designation in Sept 2025, so the record shows about a year from designation to authorization. Most other surgical robots we track already sit at stage 5, but their latest entries cover orders and placements. Virtuoso has not reached that point on our record yet.
Virtuoso Surgical Robotic System, from Virtuoso Surgical, is at stage 5 of 5 on our ladder: regulator-cleared or mass market. This event is one of the milestones that placed it there.
Human help: The maker hasn't said whether people help it remotely.
Written with AI from our record of Virtuoso Surgical Robotic System and checked against it: every figure appears in that record.
More on Virtuoso Surgical Robotic System
